Madrigal officer files Form 3 with no MDGL holdings

Madrigal Pharmaceuticals, Inc. filed an initial ownership report for Chief Accounting Officer Rita Thakkar.

Rhea-AI Filing Summary

Madrigal Pharmaceuticals, Inc. filed an initial ownership report for Chief Accounting Officer Rita Thakkar. The Form 3 states that no securities are beneficially owned, meaning the reporting person does not report holding any Madrigal common stock or derivative securities as of the event date. The filing is primarily administrative and does not describe any purchases, sales, or option grants.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the reporting person in the MDGL Form 3 filing?

The reporting person is Rita Thakkar, who serves as the Chief Accounting Officer of Madrigal Pharmaceuticals, Inc.

What is the event date reported in the Madrigal (MDGL) Form 3?

The Form 3 lists an event date of 01/12/2026 for the initial statement of beneficial ownership.

Does Rita Thakkar report any Madrigal (MDGL) shares owned on this Form 3?

No. The remarks section explicitly states, "No securities are beneficially owned."

Are any derivative securities reported in this MDGL Form 3?

No. Table II for derivative securities is present but contains no entries, and the remarks clarify that no securities are beneficially owned.

Is this Madrigal (MDGL) Form 3 filed by one or multiple reporting persons?

The Form 3 indicates it is filed by one reporting person, covering only Chief Accounting Officer Rita Thakkar.

What additional document is referenced in this MDGL Form 3?

The remarks reference Exhibit 24: Power of Attorney, indicating that the form was signed by /s/ Mardi Dier, as Attorney-in-Fact on 01/20/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 05:22 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Thakkar Rita

(Last) (First) (Middle)

C/O MADRIGAL PHARMACEUTICALS, INC.

200 BARR HARBOR DRIVE, SUITE 200

(Street)

WEST CONSHOHOCKEN PA 19428

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/12/2026

3. Issuer Name and Ticker or Trading Symbol
MADRIGAL PHARMACEUTICALS, INC. [ MDGL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24: Power of Attorney

No securities are beneficially owned.

	/s/ Mardi Dier, as Attorney-in-Fact	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.